Insulin pen production at an Eli Lilly factory in France. The new drug — a pill that can be taken at any time of day, with or without food — is almost unheard-of in the world of peptide drugs.
In the first clinical trial of its kind, an A.I. chatbot eased mental health symptoms among participants. The technology may someday help solve the provider shortage.
Login
